TrialAntimicrobial agents and chemotherapy2022

Safety, Tolerability, and Pharmacokinetics of the Novel Antiviral Agent Ensitrelvir Fumaric Acid, a SARS-CoV-2 3CL Protease Inhibitor, in Healthy Adults.

Ryosuke Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.